Jefferies Raises Merck Price Target to $177 From $176
Jefferies adjusted its price target for Merck to $177 from $176. The supplied body says Merck has an average rating of overweight.
Related stories
Garrett Motion Reports Quarterly Results
Garrett Motion reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 03:53 PM UTC
Canada Invests in Cohere Alongside NVIDIA and Bell, Carney Says
Canada is investing in Cohere on a commercial basis alongside private investors, including NVIDIA and Bell.
M impact | EQUITY | Oct 29, 2026, 03:53 PM UTC
Cohere to Invest at Least C$1.7 Billion in Canadian Computing Infrastructure
Cohere will remain Canadian and invest at least C$1.7 billion in new computing infrastructure in Canada by 2030, according to Carney.
M impact | EQUITY | Oct 29, 2026, 03:53 PM UTC
Canada to Invest in Cohere Alongside Private Investors Including NVIDIA
Canada is investing in Cohere on a commercial basis alongside private investors, including NVIDIA and Bell, Carney said.
L impact | EQUITY | Oct 29, 2026, 03:53 PM UTC
Canada plans to invest up to C$1.6 billion in Cohere
Prime Minister Mark Carney said Canada plans to invest up to C$1.6 billion in Cohere.
M impact | EQUITY | Oct 29, 2026, 03:53 PM UTC
Medline Issues Urgent Notice for Market Exit of Beds, Accessories
Medline issued an urgent notice for the market exit of all Medline-brand beds and accessories.
M impact | EQUITY | Oct 29, 2026, 03:52 PM UTC